Cancer Med Might Be Powerful Treatment for MS

THURSDAY, July 14, 2022 -- A drug used " off-label " for multiple sclerosis (MS) is more effective than a standard medication at preventing symptom flare-ups, a new clinical trial has found. The drug, called rituximab, is approved in the United States...
Source: Drugs.com - Daily MedNews - Category: General Medicine Source Type: news